Subscribe to our newsletter to receive the latest product updates and special offers

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Revenue Breakdown and Options Chain

Gain deeper insights into company revenues with a detailed analysis of revenue sources.
Explore the updated Options feature, providing in-depth data, and a 3D viewing option.

Last Close
Mar 04 04:00PM ET
81.74
Dollar change
-2.01
Percentage change
-2.40
%
Index- P/E- EPS (ttm)-1.97 Insider Own5.29% Shs Outstand80.04M Perf Week-5.02%
Market Cap6.88B Forward P/E- EPS next Y-4.13 Insider Trans-2.16% Shs Float79.74M Perf Month26.40%
Income-153.61M PEG- EPS next Q-1.46 Inst Own64.28% Short Float18.65% Perf Quarter22.49%
Sales371.21M P/S18.54 EPS this Y-203.03% Inst Trans-0.05% Short Ratio5.51 Perf Half Y61.80%
Book/sh23.52 P/B3.48 EPS next Y29.78% ROA-6.87% Short Interest14.87M Perf Year71.29%
Cash/sh20.12 P/C4.06 EPS next 5Y- ROE-8.17% 52W Range37.55 - 91.10 Perf YTD30.58%
Dividend Est.- P/FCF- EPS past 5Y10.83% ROI-7.29% 52W High-10.27% Beta1.78
Dividend TTM- Quick Ratio17.54 Sales past 5Y33402.13% Gross Margin65.88% 52W Low117.68% ATR (14)4.68
Dividend Ex-Date- Current Ratio17.54 EPS Y/Y TTM76.72% Oper. Margin-53.64% RSI (14)56.92 Volatility5.38% 6.30%
Employees407 Debt/Eq0.13 Sales Y/Y TTM30885.48% Profit Margin-41.38% Recom2.23 Target Price85.04
Option/ShortYes / Yes LT Debt/Eq0.12 EPS Q/Q177.83% Payout- Rel Volume0.59 Prev Close83.75
Sales Surprise42.76% EPS Surprise1559.13% Sales Q/Q3353333.33% EarningsFeb 21 BMO Avg Volume2.70M Price81.74
SMA204.94% SMA5018.14% SMA20040.27% Trades Volume1,604,815 Change-2.40%
Date Action Analyst Rating Change Price Target Change
Feb-15-24Initiated Wolfe Research Peer Perform
Dec-11-23Downgrade TD Cowen Market Perform → Underperform $30
Oct-17-23Downgrade Cantor Fitzgerald Overweight → Neutral
Sep-27-23Initiated Mizuho Buy $82
Aug-17-23Upgrade Citigroup Neutral → Buy
May-30-23Initiated William Blair Outperform $75
Apr-13-23Initiated Cantor Fitzgerald Overweight $72
Mar-21-23Initiated Bernstein Mkt Perform $44
Mar-17-23Initiated Bryan Garnier Buy $70
Mar-07-23Initiated Robert W. Baird Neutral $46
Mar-04-24 08:48AM
Feb-29-24 05:32PM
06:31AM
05:50AM
Feb-27-24 12:00PM
08:50AM Loading…
Feb-26-24 08:50AM
06:45AM
Feb-23-24 10:01AM
Feb-22-24 07:37AM
04:00AM
Feb-21-24 04:32PM
10:15AM
07:30AM
Feb-20-24 05:02AM
Feb-19-24 04:08PM
01:45AM Loading…
01:45AM
Feb-16-24 02:19PM
07:31AM
Feb-15-24 08:30AM
Feb-14-24 08:15AM
Feb-13-24 01:22PM
10:00AM
08:30AM
02:30AM
Feb-10-24 05:09PM
Feb-09-24 06:00PM
Feb-08-24 02:59AM
Feb-07-24 10:00AM
09:09AM
Feb-05-24 08:00AM
02:35PM Loading…
Feb-04-24 02:35PM
Feb-02-24 06:00PM
Feb-01-24 09:10PM
Jan-31-24 12:28PM
Jan-30-24 05:10AM
05:02AM
Jan-28-24 05:10AM
Jan-25-24 06:15PM
08:32AM
Jan-24-24 09:45AM
Jan-23-24 09:30AM
Jan-22-24 09:12AM
05:05AM
Jan-21-24 09:37AM
08:00AM
Jan-20-24 06:50AM
Jan-19-24 06:15PM
Jan-16-24 04:08PM
04:01PM
08:15AM
Jan-15-24 04:56PM
06:30AM
05:19AM
Jan-14-24 01:30PM
05:10AM
Jan-13-24 06:05AM
05:20AM
Jan-10-24 06:00AM
Jan-09-24 06:15PM
Jan-08-24 09:17AM
07:00AM
05:00AM
Jan-06-24 05:00AM
Jan-04-24 05:00AM
Jan-03-24 12:17PM
08:30AM
Jan-01-24 09:05AM
Dec-31-23 10:30AM
08:45AM
Dec-30-23 06:50AM
12:09AM
Dec-25-23 05:30AM
Dec-22-23 05:02PM
05:27AM
Dec-21-23 08:30AM
05:51AM
Dec-20-23 11:04AM
09:43AM
05:00AM
Dec-19-23 05:11PM
05:00AM
Dec-18-23 05:30AM
Dec-17-23 08:45AM
Dec-16-23 09:45AM
06:55AM
05:53AM
Dec-15-23 11:14AM
09:30AM
05:30AM
Dec-14-23 06:30AM
04:02AM
Dec-13-23 10:15AM
Dec-12-23 04:03PM
03:28PM
06:00AM
Dec-11-23 07:25PM
06:26PM
12:41PM
11:34AM
09:55AM
CRISPR Therapeutics AG is a gene editing company, which engages in the development of transformative gene-based medicines for serious diseases using its proprietary CRISPR/Cas9 platform. Its CRISPR/Cas9 platform is a gene editing technology that allows for precise, directed changes to genomic DNA. The firm offers a portfolio of therapeutic programs across a broad range of disease areas including hemoglobinopathies, oncology, regenerative medicine, and rare diseases. The company was founded by Rodger Novak, Emmanuelle Charpentier, Shaun Patrick Foy, Matthew Porteus, Daniel Anderson, Chad Cowan, and Craig Mellow on October 31, 2013 and is headquartered in Zug, Switzerland.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Kulkarni SamarthChief Executive OfficerFeb 20Sale79.676,370507,498194,257Feb 21 05:45 PM
KASINGER JAMES R.General Counsel and SecretaryFeb 20Sale79.671,913152,40957,371Feb 21 05:45 PM
Kulkarni SamarthChief Executive OfficerFeb 15Option Exercise19.1220,000382,400207,377Feb 16 05:45 PM
Kulkarni SamarthChief Executive OfficerFeb 15Sale80.3620,0001,607,177187,377Feb 16 05:45 PM
Kulkarni SamarthChief Executive OfficerJan 29Option Exercise19.1250,000956,000237,377Jan 31 05:45 PM
Kulkarni SamarthChief Executive OfficerJan 29Sale60.5150,0003,025,573187,377Jan 31 05:45 PM
Kulkarni SamarthChief Executive OfficerJan 16Option Exercise19.1220,000382,400207,377Jan 18 05:45 PM
Kulkarni SamarthChief Executive OfficerJan 16Sale62.5020,0001,250,058187,377Jan 18 05:45 PM
Kulkarni SamarthChief Executive OfficerMay 30Option Exercise19.1225,000478,000412,377Jun 01 05:44 PM
Kulkarni SamarthChief Executive OfficerMay 30Sale64.8825,0001,621,894387,377Jun 01 05:44 PM
Kulkarni SamarthChief Executive OfficerApr 25Option Exercise19.1225,000478,000412,377Apr 27 05:37 PM
Kulkarni SamarthChief Executive OfficerApr 25Sale50.6725,0001,266,638387,377Apr 27 05:37 PM
Kulkarni SamarthChief Executive OfficerMar 29Option Exercise19.1225,000478,000412,377Mar 31 05:49 PM
Kulkarni SamarthChief Executive OfficerMar 29Sale44.4625,0001,111,504387,377Mar 31 05:49 PM